• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Apotex`s Generic Emtricitabine;TAF Receives Approval in the U.S.

    FDA

    FDA Confirms Paragraph IV Patent Litigation for Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets

    FDA

    FDA Confirms Paragraph IV Patent Litigation for Emtricitabine and Tenofovir Alafenamide Fumarate Tablets

    FDA

    ViiV Healthcare presents three-year switch data for Dovato

    BUSINESSWIRE

    FDA Confirms Paragraph IV Patent Challenge of Vemlidy 208464 (Tenofovir Alafenamide Fumarate) Tablets

    FDA

    FDA Confirms Paragraph IV Patent Challenge of Descovy 208215 (Emtricitabine and Tenofovir Alafenamide Fumarate) Tablets

    FDA

    FDA Confirms Paragraph IV Patent Challenge of Odefsey 208351 (Emtricitabine, Rilpivirine Hydrochloride and Tenofovir Alafenamide Fumarate )Tablets

    FDA

    Gilead Sciences` Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) Receives Approves in Europe

    EMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.